Literature DB >> 32351648

Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI.

Guo-Xiong Chen1, Hong-Na Wang1, Jin-Lin Zou1, Xiao-Xu Yuan1.   

Abstract

BACKGROUND: This study investigated the effects of the intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction (STEMI) after emergency percutaneous coronary intervention (PCI).
METHODS: Seventy-eight STEMI patients with age >65 years who underwent emergency PCI were consecutively enrolled. These patients received conventional PCI and were randomly divided into a control group and a treatment group (n=39 per group). The control group received an intracoronary injection of tirofiban followed by a maintenance infusion for 36 hours after surgery. The treatment group received intracoronary injection of tirofiban and nicorandil, and then intravenous infusion of tirofiban and nicorandil 36 hours after surgery. The following parameters were measured: TIMI grade, corrected TIMI frame count (cTFC), TIMI myocardial perfusion grade (TMPG), ST-segment resolution (STR) rate 2 hours post-operatively, resolution of ST-segment elevation (STR) at 2 hours postoperatively, peak level of serum CK-MB, left ventricular end diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) at 7-10 days postoperatively, and major adverse cardiac events (MACEs) in-hospital and within 30 days post-operatively.
RESULTS: Compared with the control group, more patients in the treatment group had TIMI 3 and TMPG 3, and STR after PCI was significantly higher. The treatment group also had significantly lower cTFC, lower infarction relative artery (IRA), lower peak CK-MB, and no reflow ratio after PCI. The treatment group had significantly higher LVEDD and LVEF but lower incidence of MACEs than the control group.
CONCLUSION: The intracoronary injection of nicorandil combined with tirofiban can effectively improve myocardial reperfusion in elderly STEMI patients after emergency PCI and improve short-term prognoses. Copyright: © World Journal of Emergency Medicine.

Entities:  

Keywords:  Acute ST-elevation myocardial infarction; Elderly; Emergency coronary intervention; Myocardial reperfusion; Nicorandil; Tirofiban

Year:  2020        PMID: 32351648      PMCID: PMC7183914          DOI: 10.5847/wjem.j.1920-8642.2020.03.005

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  23 in total

1.  Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention.

Authors:  Ronen Jaffe; Thierry Charron; Geoffrey Puley; Alexander Dick; Bradley H Strauss
Journal:  Circulation       Date:  2008-06-17       Impact factor: 29.690

2.  Safety and efficacy of Tirofiban in STEMI-patients.

Authors:  Lisa Dannenberg; Georg Wolff; David Naguib; Martin Pöhl; Saif Zako; Carolin Helten; Philipp Mourikis; Bodo Levkau; Thomas Hohlfeld; Tobias Zeus; Malte Kelm; Volker Schulze; Amin Polzin
Journal:  Int J Cardiol       Date:  2018-09-13       Impact factor: 4.164

3.  Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Nuccia Morici; Stefano Savonitto; Luca A Ferri; Daniele Grosseto; Irene Bossi; Paolo Sganzerla; Giovanni Tortorella; Michele Cacucci; Maurizio Ferrario; Gabriele Crimi; Ernesto Murena; Stefano Tondi; Anna Toso; Nicola Gandolfo; Amelia Ravera; Elena Corrada; Matteo Mariani; Leonardo Di Ascenzo; A Sonia Petronio; Claudio Cavallini; Giancarlo Vitrella; Roberto Antonicelli; Federico Piscione; Renata Rogacka; Laura Antolini; Gianfranco Alicandro; Carlo La Vecchia; Luigi Piatti; Stefano De Servi
Journal:  Am J Med       Date:  2018-11-14       Impact factor: 4.965

4.  Potential mechanisms of the acute coronary syndrome presentation in patients with the coronary slow flow phenomenon - insight from a plasma proteomic approach.

Authors:  Victoria A Kopetz; Megan A S Penno; Peter Hoffmann; David P Wilson; John F Beltrame
Journal:  Int J Cardiol       Date:  2011-10-02       Impact factor: 4.164

Review 5.  Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered Approach.

Authors:  Benoit Lattuca; Mathieu Kerneis; Michel Zeitouni; Guillaume Cayla; Paul Guedeney; Jean-Philippe Collet; Gilles Montalescot; Johanne Silvain
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

6.  Combination of ACE inhibitor with nicorandil provides further protection in chronic kidney disease.

Authors:  Takeshi Shiraishi; Yoshifuru Tamura; Kei Taniguchi; Masato Higaki; Shuko Ueda; Tomoko Shima; Michito Nagura; Takahiko Nakagawa; Richard J Johnson; Shunya Uchida
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-15

Review 7.  Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban.

Authors:  Arnoud W J van 't Hof; Marco Valgimigli
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Comparison between Emergency Severity Index and Heart Failure Triage Scale in heart failure patients: A randomized clinical trial.

Authors:  Ahmad Pouyamehr; Amir Mirhaghi; Mohammad Davood Sharifi; Ali Eshraghi
Journal:  World J Emerg Med       Date:  2019

9.  Treatment choices in elderly patients with ST: elevation myocardial infarction-insights from the Vital Heart Response registry.

Authors:  Olga Toleva; Quazi Ibrahim; Neil Brass; Sunil Sookram; Robert Welsh
Journal:  Open Heart       Date:  2015-06-24

10.  Nationwide real-world database of 20,462 patients enrolled in the Japanese Acute Myocardial Infarction Registry (JAMIR): Impact of emergency coronary intervention in a super-aging population.

Authors:  Sunao Kojima; Kensaku Nishihira; Misa Takegami; Yoko M Nakao; Satoshi Honda; Jun Takahashi; Morimasa Takayama; Hiroaki Shimokawa; Tetsuya Sumiyoshi; Hisao Ogawa; Kazuo Kimura; Satoshi Yasuda
Journal:  Int J Cardiol Heart Vasc       Date:  2018-06-14
View more
  9 in total

1.  Optimized strategy of rotational atherectomy of underexpanded coronary stents in patients with acute coronary syndrome.

Authors:  Kun Cui; You-Quan Shi; Yuan-Zheng Zhang; Zheng-Gong Li; Chang-Ling Li
Journal:  World J Emerg Med       Date:  2021

2.  Predictors of recurrent angina in patients with no need for secondary revascularization.

Authors:  Tian Xu; Ya Li; Li-Ding Zhao; Guo-Sheng Fu; Wen-Bin Zhang
Journal:  World J Emerg Med       Date:  2021

3.  Effect of Tirofiban Injection on vascular endothelial function, cardiac function and inflammatory cytokines in patients with acute myocardial infarction after emergency Percutaneous Coronary Intervention.

Authors:  Shi-Xin Kang; Xiao-Min Meng; Jing Li
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

4.  Application of tirofiban in patients with acute myocardial infarction complicated with diabetes and undergoing emergency interventional therapy.

Authors:  Xiuying Tang; Runjun Li; Lixiang Ma; Ting Zhang
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

5.  Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention.

Authors:  Yan Yu; Bao-Ping Yang
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

6.  Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ning Geng; Li Ren; Lisheng Xu; Deling Zou; Wenyue Pang
Journal:  BMC Cardiovasc Disord       Date:  2021-10-10       Impact factor: 2.298

7.  Clinical Nursing Pathway Improves Therapeutic Efficacy and Quality of Life of Elderly Patients with Acute Myocardial Infarction.

Authors:  Yumei Zhang; Guichun Chen; Dandan Huang; Shue Luo
Journal:  Comput Math Methods Med       Date:  2022-03-15       Impact factor: 2.238

8.  Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality.

Authors:  Xin Lu; Xue Wang; Yanxia Gao; Joseph Harold Walline; Shiyuan Yu; Zengzheng Ge; Mubing Qin; Huadong Zhu; Yi Li
Journal:  ESC Heart Fail       Date:  2022-03-14

9.  The effects of Anisodamine-Tirofiban Combined Therapy in acute myocardial infarction treated with Percutaneous Coronary Intervention (PCI).

Authors:  Yan Jiao; Xiaoying Fu; Qingxin Liu; Wei Zhang
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.